To systematically compare their mechanisms and therapeutic outcomes, Table 3 summarizes current GAS5-targeted interventions, including their molecular targets, biological effects, and applications in atherosclerosis, diabetes, and associated vascular pathologies. Here, GAS5 is linked to diabetes mellitus.